July 10th was a good day for OncoVista Innovative Therapies (OTCQB: OVIT) who made a gain of 164.03%. The previous day’s close was $0.03 and rose 0.0497 today to $0.08. See a free stock report of this company at LeadingStockAlerts.com.
The Company had been doing very well going as high as $0.25 early in 2013. Since then it declined slowly but never dropping below $0.10. In fact $0.03 was the stock’s lowest price all year even though the very next day the stock bounced back significantly.
The Company recently got approval from the FDA for clinical trials on their new drug candidate to fight solid tumors. The drug shows great promise for colon, breast, gastric and prostate cancer.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Many small cap and micro cap companies lack the recognition required to raise the resources needed to increase equity appreciation and liquidity. This community has traditionally been shunned by Wall Street Institutions and has been forced to look elsewhere for exposure.This site understands that there are many explosive companies waiting to be discovered by the retail investment community. These firms do not have the technology or time to introduce themselves to a wide range of potential investors. Our site allows its clients to focus on achieving their business goals while taking over the task of introducing the company to millions of potential investors.